-
-
-
-
-
-
-
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
-
-
-
-
-
-
-
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
-
-
-
-
-
-
-
BioNTech SE (BNTX) Tops Q3 EPS by 236c
-
-
-
-
-
-
-
HSBC Upgrades BioNTech (BNTX) to Buy
-
-
-
-
-
-
-
WuXi Biologics Reports Solid 2023 Annual Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
1,231,838 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


